Summary
This 8-K filing by Edwards Lifesciences (EW) on April 23, 2015, primarily serves to announce their financial results for the first quarter of 2015. The key information is contained within the press release furnished as Exhibit 99.1, detailing the company's performance during the period. Investors should review this press release for specific figures related to revenue, profitability, and any forward-looking guidance provided by the company.
Key Highlights
- 1Edwards Lifesciences announced its first quarter 2015 financial results on April 23, 2015.
- 2The company filed an 8-K to report these financial results, including a furnished press release (Exhibit 99.1).
- 3The press release details the company's operational and financial performance for the first quarter of 2015.
- 4Investors are directed to Exhibit 99.1 for the specific financial data and commentary.
- 5This filing is a routine disclosure of quarterly earnings.
- 6The information provided is subject to the standard disclaimer that it is furnished, not filed, for the purposes of the Securities Exchange Act of 1934.
Frequently Asked Questions
The main purpose of this 8-K filing is to officially announce and provide details of Edwards Lifesciences' financial results for the first quarter of 2015, as reported in their press release.
The specific financial details are located in the press release dated April 23, 2015, which is furnished as Exhibit 99.1 to this 8-K filing. This exhibit is incorporated by reference.
No, the information furnished under Item 2.02, including the press release, is typically considered 'furnished,' not 'filed,' for the purposes of the Securities Exchange Act of 1934, as amended. This means it doesn't carry the same liability as formally filed information.